11/14/2024
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:51 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2024
12:39 PM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
3:12 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:10 PM | Boudes Pol F (Reporting)
Galectin Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/26/2024
7:08 AM | Galectin Therapeutics (Issuer)
Zordani Richard A. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
6:50 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
7:41 AM | Galectin Therapeutics (Issuer)
Jamil Khurram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
7:38 AM | Galectin Therapeutics (Issuer)
Jamil Khurram (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/01/2024
6:50 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2024
8:43 AM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4/A | |
07/23/2024
8:38 AM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
12:55 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
6:50 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2024
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
1:14 PM | Galectin Therapeutics (Issuer)
Zordani Richard A. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
12:27 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
10:37 AM | CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
04/09/2024
3:42 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
6:51 AM | Galectin Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/29/2024
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
11:50 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
7:50 AM | CARSON BENJAMIN SR (Reporting)
Galectin Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/16/2024
10:23 AM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
7:07 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
7:41 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
10:42 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
3:50 PM | CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
12/01/2023
3:38 PM | 10X Fund, L.P. (Filed by)
Galectin Therapeutics (Subject)
| Form SC 13D/A | |
12/01/2023
7:05 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
